May 10, 2023 / 09:20PM GMT
Craig William Bijou - BofA Securities, Research Division - Research Analyst
Good afternoon. My name is Craig Bijou. I'm one of the medical device analysts here at BofA. And it's a pleasure to welcome Paragon 28. And from the company, Albert De Costa, the CEO; and Steve Deitsch, CFO. So thank you.
Questions and Answers:
Craig William Bijou - BofA Securities, Research Division - Research AnalystI want to start, you reported Q1 results last week. So I just kind of want to start it with maybe a little bit of a recap. Obviously, growth was pretty strong, 27% constant currency basis on what was a pretty tough comp in the prior year. So if you could just go into a little bit of what drove the strength in the quarter? I know you had mentioned 20% plus growth in the U.S. across all of your foot and ankle segments. But maybe I'll push you a little bit on that too and see if there's anything that stood out in the quarter, but would love to hear your view.
Albert DaCosta - Paragon 28, Inc. - Co-Founder, Chairman, President & CEO
Trustpilot
